Esketamine (Spravato) nasal spray offers a breakthrough for those battling treatment-resistant depression. Studies show nearly 77% of patients using esketamine with an oral antidepressant experience significant symptom [...]
What Else Can I Do While on SPRAVATO® to Manage Depression? Are you considering SPRAVATO® (esketamine) for treatment-resistant depression? Treatment-resistant depression sounds discouraging and can be a [...]
Spravato is a nasal spray that must be administered by a professional in a Spravato-approved clinic—like the TMS Institute of Arizona. It’s often called a type “ketamine [...]
The Department of Veterans Affairs (VA) just received $40 million to research which is most effective in helping veterans with treatment-resistance depression (TRD)—Spravato or aripiprazole. Understandably, many [...]
If you have treatment-resistant major depressive disorder (MDD), with or without suicidal ideation, you may need treatment beyond your current medication. That’s why the TMS Institute of [...]
Disclaimer: this piece was originally published in Australia, so the perspective on “Ketamine” and Spravato might not be identical to that held in the United States. Additionally, [...]
Spravato is the first prescription nasal spray used in conjunction with oral antidepressants to help treat adults experiencing treatment-resistant depression. It was designed for those with major [...]
© Copyright 2024 | TMS Institute of Arizona | All Rights Reserved
Where Advanced Mental Health and Depression Treatment Meet Excellence
Specialists in TMS | MeRT | Brain Stimulation
9746 N 90th Pl, Ste 207
Scottsdale, AZ 85258
Hours: 8 am – 5 pm M-F
